Trabectedin plus radiotherapy on symptomatic advanced sarcoma patients: Results from the SYNERGIAS study - A Spanish group for research in sarcoma (GEIS) phase II study

被引：0

作者：

Martin-Broto, J. ^{[1
]}

Kopeckova, K. ^{[2
]}

Azinovic, I. ^{[3
]}

Cruz Jurado, J. ^{[4
]}

Guzman, L. ^{[3
]}

Alvarez, R. M. ^{[5
]}

Casado Herraez, A. ^{[6
]}

Valverde Morales, C. M. ^{[7
]}

Sanchez, A. Redondo ^{[8
]}

Teres Lleida, R. ^{[9
]}

Alvarez Gonzalez, A.

Dolado, M. C. ^{[10
]}

Doval, A. ^{[11
]}

Belinchon, B. ^{[12
]}

Merino, J. A. ^{[13
]}

Mendez, R. ^{[14
]}

Ledesma, P. ^{[15
]}

Gutierrez, A. ^{[16
]}

Da Silva Moura, D. ^{[17
]}

Hindi Muniz, N. ^{[1
]}

机构：

[1] Hosp Univ Fdn Jimenez Diaz, Med Oncol Dept, Madrid, Spain

[2] Hosp Santa Creu & Sant Pau, Radiat Oncol, Barcelona 5, Spain

[3] Fdn Jimenez Diaz Univ Hosp, Radiat Oncol, Madrid, Spain

[4] Hosp Univ Canarias, Med Oncol Dept, Santa Cruz De Tenerife, Spain

[5] Hosp Gen Univ Gregorio Maranon, Med Oncol, Madrid, Spain

[6] Hosp Clin Univ San Carlos, Med Oncol Dept, Madrid, Spain

[7] Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain

[8] Hosp Univ La Paz, Dept Oncol Med, Madrid, Spain

[9] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Consultes Externes, Barcelona, Spain

[10] Complejo Hosp Univ Canarias, Radiat Oncol, San Cristobal De La Lagu, Spain

[11] Hosp Clin Univ San Carlos, Radiat Oncol, Madrid, Spain

[12] Hosp Univ La Paz, Radiat Oncol, Madrid, Spain

[13] Fdn Jimenez Diaz Univ Hosp, Pathol, Madrid, Spain

[14] Hosp Clin San Carlos, Radiol, Madrid, Spain

[15] Sofpromed, Palma de Mallorca, Spain

[16] Hosp Univ Son Espases, Hematol, Palma de Mallorca, Spain

[17] Hosp Univ Virgen Rocio, Adv Therapies & Biomarkers Oncol Grp, Seville, Spain

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1155

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1926P

引用

页码：S1035 / S1036

页数：2

共 50 条

[1] Predictive gene signature for trabectedin efficacy in advanced soft-tissue sarcoma: A Spanish group for research in sarcoma (GEIS) study
Silva Moura, David
Cordero Varela, Juan A.
Alvarez, Ramiro
Agra Pujol, Carolina
Izquierdo, Francisco
Ramos, Rafael
Ortega, Luis
Martin-Davila, Francisco
Hernandez Leon, Nieves
Romagosa, Cleofe
Vaz-Salgado, Maria Angeles
Lavernia, Javier
Bague, Silvia
Mayodormo-Aranda, Empar
Mondaza-Hernandez, Jose Lucinio
Renshaw-Calderon, Marta
Hindi, Nadia
Valverde Morales, Claudia
Martinez-Trufero, Javier
Martin Broto, Javier
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[2] Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study
Martin-Liberal, Juan
Lopez-Pousa, Antonio
Martinez-Trufero, Javier
Martin-Broto, Javier
Cubedo, Ricardo
Lavernia, Javier
Redondo, Andres
Antonio Lopez-Martin, Jose
Mulet-Margalef, Nuria
Sanjuan, Xavier
Tirado, Oscar M.
Garcia-del-Muro, Xavier
TARGETED ONCOLOGY, 2018, 13 (01) : 81 - 87
[3] Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study
Juan Martin-Liberal
Antonio López-Pousa
Javier Martínez-Trufero
Javier Martín-Broto
Ricardo Cubedo
Javier Lavernia
Andrés Redondo
José Antonio López-Martín
Nùria Mulet-Margalef
Xavier Sanjuan
Òscar M. Tirado
Xavier Garcia-del-Muro
Targeted Oncology, 2018, 13 : 81 - 87
[4] Phase II trial of gemcitabine plus rapamycin as second line in advanced osteosarcoma: A Spanish Group for Sarcoma Research (GEIS) Study.
Martin Broto, Javier
Redondo, Andres
Maria Valverde, Claudia
Vaz Salgado, Maria Angeles
Mora, Jaume
Garcia del Muro, Xavier
Sancho Marquez, Maria Pilar
Martinez-Trufero, Javier
Diaz Beveridge, Robert
Gutierrez, Antonio
Blay, Pilar
Tous, Cristina
Luna Fra, Pablo
Lopez-Pousa, Antonio
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[5] Predictive role of FAS for trabectedin in second lines of advanced soft tissue sarcoma (ASTS): A Spanish group for research on sarcoma (GEIS) study.
Broto, Javier Martin
Marcilla, David
Ramos, Rafael
Moura, David Silva
Alvarez, Ramiro
Hernandez, Nieves
Pujol, Carolina Agra
Mayordomo, Empar
Romagosa, Cleofe
Bague, Silvia
Reguero, Eugenia
Cruz, Julia
Martin, Francisco Javier
Gutierrez, Antonio
Cruz, Josefina
Alvarez, Rosa Maria Alvarez
Beveridge, Robert Diaz
Morales, Claudia Maria Valverde
Lopez-Pousa, Antonio
Martinez-Trufero, Javier
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[6] Phase I study of sorafenib plus ifosfamide in patients with advanced soft tissue and bone sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study.
Garcia del Muro, X.
Lopez-Pousa, A.
Martin Broto, J.
Cubedo, R.
Jimenez Colomo, L.
Gallego, O.
Prevencio-Pulla, M.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[7] Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups
Gronchi, Alessandro
Hindi, Nadia
Cruz, Josefina
Blay, Jean-Yves
Lopez-Pousa, Antonio
Italiano, Antoine
Alvarez, Rosa
Gutierrez, Antonio
Rincon, Inmaculada
Sangalli, Claudia
Perez Aguiar, Jose Luis
Romero, Jesus
Morosi, Carlo
Sunyach, Marie Pierre
Sanfilippo, Roberta
Romagosa, Cleofe
Ranchere-Vince, Dominique
Dei Tos, Angelo P.
Casali, Paolo G.
Martin-Broto, Javier
ECLINICALMEDICINE, 2019, 9 : 35 - 43
[8] Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study
J. Martín-Liberal
A. López-Pousa
J. Martín Broto
R. Cubedo
O. Gallego
E. Brendel
O. M. Tirado
X. García del Muro
Investigational New Drugs, 2014, 32 : 287 - 294
[9] Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study
Martin-Liberal, J.
Lopez-Pousa, A.
Martin Broto, J.
Cubedo, R.
Gallego, O.
Brendel, E.
Tirado, O. M.
Garcia del Muro, X.
INVESTIGATIONAL NEW DRUGS, 2014, 32 (02) : 287 - 294
[10] Phase II trial of ifosfamide in combination with sorafenib in patients with advanced soft tissue sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study.
Garcia del Muro, Xavier
Maurel, Joan
Martinez Trufero, Javier
Lavernia, Javier
Lopez-Pousa, Antonio
De Las Penas, Ramon
Cubedo, Ricardo
Fra, Joaquin
Casado, Antonio
De Juan, Ana
Jimenez Colomo, Laura
Martin Broto, Javier
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)

← 1 2 3 4 5 →